IPMMA Magazine : July - September 2020

IPMMA NEWS Kaushik Desai - Advisor IPMMA need to start somewhere and gradually pick up the
momentum. Collaborative approach with government
This pandemic has been unprecedented, and the funded research institutes should be prioritized,
role of digital and automation is evident from particularly Council of Scientific and Industrial
this duration. We are communicating now Research (CSIR) and National Institute of
almost completely digitally than physically. Like every Pharmaceutical Education and Research (NIPER)
other industry the set of challenges this pandemic has accelerating innovation focused projects. Several
offered, Pharma machinery industry is not an members of IPMMAhave started implementing IIOT,
exception. AI, Machine Learning tools and more, which will help
us to be in line with the global digital scenario.
The MSME's have suffered the most in terms of supply
chain complexity, workforce availability and cash flow. We also need to work on our Industry-Academia
Indian Pharma Machinery Manufacturers' Association interface since the pace of change in education system
(IPMMA) mainly consists of members from MSME is not at par with the technology evolution, it has to be
sector. Many such issues have not deterred pharma and dynamically updated. The government has recently
machinery sector to rise to the occasion of taken steps for strengthening this interface by the new
uninterrupted supply not just in India but globally. National Education Policy (NEP 2020). IPMMA has plan
MSME has played a major role in this resurgence and to collaborate with institutes to start certified course in
60% of the products of this industry are provided Pharmaceutical Engineering aimed at creating an
MSME's. employable workforce.

One positive outcome of this pandemic is that the Pharma industry cannot grow on its own, Pharma
stakeholders including government have come machinery industry has to grow with it. We at IPMMA
together on a common platform in framing supporting are working with our members for supporting
policies to mitigate the ongoing challenges. The government initiative of Make In India. We all should
initiative of cluster development and building work collectively towards our common mission of
innovation centers gives MSME support to a great Atmanirbhar Bharat.
extent.

Industry should have collaborative approach towards
R&D and innovation, although we have miles to go, we

Mr. Rahul Guha - MD & Partner, The Boston Consulting Group

Pharma industry in India always had a growth drugs. However, in R&D we have a long way to go
head room. Per capita spending in India is $20 which needs an entire eco-system for its support.
which is far below than many countries, in US Currently in India working on a drug discovery program
it's close to $1,000.The pandemic has brought in a is a game of few big players who carry that capacity
huge awareness about health. We have been globally while a small or medium scale player would need that
competitive in pricing and capable of providing good support to complete the eco-system.
quality medicines. Most pharma companies have
recognized the opportunity as the demands continues Atmanirbhar Bharatis definitelya great initiative that
to be stable. As the industry players ramp up their many are rooting for, however in principal we need
capacities a huge surge in the demand in packaging some concrete execution to reach that potential. We
and ancillary industries is seen. need to bridge the viability gap of 10% in making
Atmanirbhar Bharata reality. Government support
India is currently the third largest supplier for generic definitely can boost it by providing economic power,
drugs in the world. With this it is clear that India is a providing incentives for skilled manpower.
destination of choice for sourcing pharmaceutical

48 PHARMA PRO & PACK | JULY - SEPTEMBER 2020 www.ipmma.org



IPMMA NEWS IPMMA Cluster: Contributing to
Nation's workforce development

The Ministry of Skill Development and empower and capacitate MSMEs to participate in
Entrepreneurship (MoSDE), Gov of India formal apprenticeship system through a cluster
through Directorate General Training had approach.
announced the formation of Industry Clusters for
IndustryApprenticeship Initiative (IAI) under the second Applications were invited from all the eligible and
phase of Skills Strengthening for Industrial Value interested Industry Cluster (IC)/ Industry Association
Enhancement (STRIVE) a project jointly funded by Govt (IA) registered as Society/Trust/Section 8 company for
of India and the World bank. IAI is an initiative to execution of the project during the project period with
the maximum funding of Rs.OneCrore per IC fromGovt
of India.

IPMMA has taken yet another step in its contribution to
our nation's development. IPMMA is contributing to
this initiative by forming an IPMMA Cluster and
applying for the scheme with 23 members supporting
the cause placing their requirement of a total of 215
apprentices, eventually employing them in their
respective organization.One of our esteemed IPMMA
member Oswin D'Souza, Director - Osworld Scientific
Equipments Pvt. Ltd is representing IPMMA for this
wonderful initiative.IPMMA is proud to be a part of this
initiative which will help in 'Skilling a Nation' as well as
provide employment to the citizens.

WOMEN IN PHARMA Pharmacist as new EMA Executive Director

The EMA Management Board has nominated she leads on WHO's global work on health technologies
Emer Cooke as the new Executive Director of the regulation, including prequalification, regulatory
Agency. At an extraordinary virtual session on 25 systems strengthening and safety activities. Her role
June, the Board selected Emer Cooke from a shortlist of also covers assurance of quality, safety, efficacy and
candidates created by the EuropeanCommission. performance of health technologies in close
conjunction with member states and international
Emer Cooke, an Irish national, is currently the Director partners.
of the Regulation and Prequalification Department at
the World Health Organization (WHO) in Geneva, a Ms Cooke has 30 years' experience in international
position she has held since November 2016. In this role regulatory affairs, 18 years of which were in leadership
roles. She worked for the pharmaceutical unit of the
European Commission from 1998 to 2002 and at EMA
between 2002 and 2016, where she held positions
including Head of Inspections and Head of International
Affairs.

Ms Cooke holds a degree in pharmacy from Trinity
College, Dublin in Ireland. She has additional Masters
degrees in Science and in Business Administration, also
fromTrinity.

Source: European MedicinesAgency

50 PHARMA PRO & PACK | JULY - SEPTEMBER 2020 www.ipmma.org



NATIONAL PHARMA Mission Atmanirbhar in Pharma

BR Sikri dependent on China only to the extent of 0.3 per cent.
However, due to the globalisation of Indian pharma
Chairman - FOPE companies and an increase in focus on formulations
(Federa on of Pharma Entrepreneurs) business prompted the increase in sourcing of APIs
from China.The primary reason for sourcing from China
BR Sikri, Chairman, FOPE (Federation of was lost costs of production due to various factors
Pharma Entrepreneurs), highlights that the including ease of doing business, fast track approvals,
environmental flexibility, regulatory approvals on a
pharma sector is key to India's economic prompt basis, cheaper land cost, cheaper power, the
progress and ensuring its self-reliance in APIs, refund of duty draw back etc.
KSMs and intermediates is the need of the hour
On the other hand, India had different challenges such
Let us keep in mind that India is not a weak as inadequate infrastructure, long timelines for
economy. We are a strong economy. Despite environmental clearances, complex regulatory
pressure due to COVID-19, terrorist problem and structure and price volatility due to high import
threat of war from China, India has proven its strength. dependency, higher power tariff, higher manpower
As per World Bank projections, India will be performing cost etc.
at 3.2 per cent.
However, the Government of India woke up in 2015 and
The attack by coronavirus is not less than an attack in a the same year was declared as the 'Year of APIs' by
war because it has exposed the dependability of the former Chemicals and Fertilisers Minister, late Anant
Indian pharma sector on China.As per a recent report by Kumar, but unfortunately, it remained only on paper
CII and KPMG, 68 per cent of APIs/intermediates/KSMs and no scheme was available for practical
are being sourced from a single country i.e.China. implementation. Many committees were formed to
have a domestic strong API industry but
Due to the quarantine policies adopted by different recommendations of these committees started
provinces of China in response to COVID-19, the accumulating dust in the cupboards of various
supplies to India, in particular, were affected by the government corridors.
disruption of logistics as well as transportation systems.
There was a sudden panic but the government as well as Then, Prime Minister Narendra Modi gave the call for
the industry united in time and were able to control the AtmaNirbharta or self-reliance in strategic sectors. He
situation. pointed out that India needs to achieve the objectives of
AtmaNirbhar Bharat to attain a higher rate of GDP
The story so far growth and to manufacture in India for the World.
Pharma is one such key sector which can strengthen the
Let us go back into history. Before 1991, we were economic position of the country.

PLI Scheme

The Government of India also announced a PLI Scheme
for 53 APIs/KSM/intermediates recently, which gave a
breather to the nation from various angles. If this
scheme is successful and if entrepreneurs come forward
to invest, then the dependability on China will come
down by 25 per cent and India will have approximately
43 per cent dependability on China. There are
indications that the government may come forward

52 PHARMA PRO & PACK | JULY - SEPTEMBER 2020 www.ipmma.org



NATIONAL PHARMA with another scheme soon, in that event, the other hand, China, due to various benefits being given
dependability will come down further. by their government, is more economical. If similar
incentives or benefits can be provided to existing
The day dependability comes down to 25 per cent or manufacturers in India, they will be able to come with
less than that, we will be in a commanding position. proposals which will be implementable in three months.
Then we will be able to negotiate with China whether it This will give a psychological jolt to China as Indian
is about pricing or supply. Till that time, China is at a capabilities to produce any products in such a short span
more advantageous position and may withhold supply will be a great surprise to them.
of key APIs or KSM suddenly, if due to any reason,
diplomatic or political, relations get adversely affected Needless to mention that India stands a bright chance
further. Therefore, it is going to be a crucial time for a of substantial growth in years to come because 97 per
couple of years and we have to be calculative in cent of countries across the world have faith in us due to
maintaining the relations with our immediate neighbor. efficacy, quality and affordability. Global population
increase, changing lifestyles, Jan Aushadhi scheme,
Strategies for self-reliance Ayushman Bharat scheme, increase in the disposable
income of individuals, self-medication, awareness of
One of the other strategies being considered by the basic medicines among the youth of our country, free
Government is to advise doctor communities to reduce distribution of medicines by the government through
prescription of antibiotics and other cephalosporins as their wellness centres are few of the factors which will
the country is hundred per cent dependent on China for propel growth in this premium industry.
their key basic raw materials.
If the government is successful in doing so, the demand All the above-mentioned strategies are possible to
for such categories of products will come down implement provided there is less red-tapism, less
drastically and China will feel the pinch of it soon. The regulatory intervention, and the government becomes
government will also focus on advising the doctors to a facilitator. The interaction between the government
prescribe old antibiotics like Co-trimoxazole, etc., a and the industry has to increase. The industry has to be
combination of Sulpha and TMP in which India has a taken into confidence while taking policy decisions. Skill
surplus and exports toChina. development is another area where we are lacking
although the Modi government announced Skill
The interaction between the Development Ministry during their last regime and for
government and the industry has to the pharma industry, the Life Science Sector Skill
Development Council (LSSSDC) was also created. A lot
increase. The industry has to be more is needed to skill not only the industry rather for
taken into confidence while taking regulators and bureaucrats. Similarly, banking reforms
and labour reforms are also needed at this crucial
policy decisions juncture as the existing laws were made during the time
of the British. The education system also needs change
Another important option for immediate relief to the as the industry has different demands and institutions
country is that the government should come forward and universities are producing students with different
with a scheme to encourage existing manufacturers to curriculum.
start production of 53 APIs, KSM, intermediates for
which government has announced the API scheme. The I am quite optimistic that we will do well in the coming
new scheme can be for a period of two to three years and days. Our problem is not unemployment, it is
when the PLI Scheme is implemented, the government productivity. I believe that equality of opportunities
can withdraw the other scheme. depends on the infrastructure of opportunity. The
infrastructure of opportunity is not roads, power,
It is understood that it is possible to produce most of the telecom of flyovers, It is the three 'Es' i.e. Education,
chemicals synthesis-based products in India by the Employment and Employability. If we balance these
existing manufacturers as they have the technologies, three “E”, we can do wonders.
spare capacities and spare utilities. What they are
lacking is the viability due to the price factor. On the Source: Express Pharma

54 PHARMA PRO & PACK | JULY - SEPTEMBER 2020 www.ipmma.org

M/S.FRANKE-GMBH MAKE
MOTION PRODUCTS

FRANKE-GMBH LINEAR MOTION GUIDES
Franke-GMBH Products Serves For Food And Medical Industries
• No Lubrication
• Hygiene
• No Rust
• Suitable For Food Industries due to High Speed
• Long Lasting Aluminum body light weight by
Stainless Steel, Non Magnetic Version Available 65% compared to other make

Special Hardened Steel wire Races Roller for High grip and needle
for guiding and wear and tear
bearings inside fully greased
M/S.FRANKE-GMBH WIRE RACE BEARINGS / SLEW RINGS

Anti-Friction low friction, Re usable outer body,
Outer body can be any material: like Alu, Steel,
Ferrous & Non-Ferrous to suit your construction
Any diameter and thickness to suit your design
-30 degree to +80 degree working temperature

NEELKAMAL AGENCY PVT LTD

No. 51A BIKASIPURA MAIN ROAD, (behind) J C INDUSTRIAL ESTATE, KANAKAPURA ROAD,
BANGALORE 560 062, INDIA. Phone: +91 80 2686 0755 Email: [email protected]

www.neelkamalagency.com

R PCI Analytics Pvt. Ltd.

A-71, Road No.22, Wagle Industrial Estate, Opp. Lodha Grandezza, Near Spraytech Circle, Thane (W) - 400 604

Tel.: +91(22) 6831 93 93. Mob : +91- 93237 00351 NABCB

Email : [email protected] Website : www.pcianalytics.in ISO 9001 : 2015

Regd.Off: 3/14,Bhandup Ind.Est.,Pannalal Compd.,LBS Marg,Bhandup (W),Mumbai-400 078 MSE * 2

CIN:-U93090MH2007PTC167442

Gas Purification Panel Mechanical Automatic Gas Monitoring Cylinder Regulator
System
Manifold

Hydrogen NGLC 32A NG-02 NGLC 32 3 in 1 Nitrogen
Generator Generator S-Series

Syringe Filter

Probe Sonicator Sonoshaker Ultrasonic Bath

HCO-01 Crimper Cuvettes-Quartz/Glass
Pcolsafe-120P CSC 250MS



®

Ami Polymer Pvt. Ltd.

“Sealing Expert in Silicone”

www.amipolymer.com | [email protected]

Specialized in Platinum Cured Silicone Tubes,
Braided Hoses & Inflatable Seals/Gaskets

Silicone/FKM/PTFE/ Fabric Reinforced Silicone Inflatable
FEP/TPE Tubes Silicone Hose Seals

FEP Retractable Coil TC-Gaskets Silicone Bellows

Comminuting Mills Sifter Sieves Rubber Sheets

CORPORATE OFFICE

319, Mahesh Indl. Estate, Opp. Silver Park, Mira-Bhayander Rd., Mira Road (E), Thane - 401104, Maharashtra, INDIA
Tel.: +91 22 28555 107 / 631 / 914 | Fax : +91 22 28555 378 | Cell.: +91 869 101 3935 / 34